Elsevier

European Urology

Volume 55, Issue 6, June 2009, Pages 1358-1367
European Urology

Surgery in Motion
Operative Details and Oncological and Functional Outcome of Robotic-Assisted Laparoscopic Radical Prostatectomy: 400 Cases with a Minimum of 12 Months Follow-up

https://doi.org/10.1016/j.eururo.2008.12.035Get rights and content

Abstract

Background

Robotic-assisted laparoscopic radical prostatectomy (RALP) using the da Vinci® surgical system (Intuitive Surgical, Sunnyvale, CA) is increasingly used for the management of localised prostate cancer.

Objective

We report the operative details and short-term oncological and functional outcome of the first 400 RALPs performed at our unit.

Design, setting and participants

From December 2003 to August 2006, 400 consecutive patients underwent RALP at our institution. A prospective database was established to record the relevant details of all RALP cases.

Surgical procedure

A six port transperitoneal approach using a 4-arm da Vinci® system was used to perform RALP. This database was reviewed to establish the operative details and oncological and functional outcome of all patients with a minimum of 12 months follow-up.

Measurements

Perioperative characteristics and outcomes are reported. Functional outcome was assessed using continence and erectile function questionnaires. Biochemical recurrence (prostate-specific antigen (PSA) ≥0.2 ng/mL) is used as a surrogate for cancer control.

Results and limitations

The mean age ± standard deviation (SD) was 60.2 ± 6 years. Median PSA level was 7.0 (interquartile range (IQR) 5.3–9.6) ng/mL. The mean operating time ± SD was 186 ± 49 mins. The complication rate was 15.75% comprising Clavien grade I-II and Clavien grade III complications in 10.5% and 5.25% of patients respectively.

The overall positive surgical margin rate was 19.2% with T2 and T3 positive margin rates of 9.6% and 42.3% respectively. The biochemical recurrence-free survival was 86.6% at a median follow-up of 22 (IQR = 15–30) months. At 12 months follow-up, 91.4% of patients were pad-free or used a security liner. Of those men previously potent (defined as Sexual Health Inventory for Men [SHIM] score ≥21) who underwent nerve-sparing RALP, 62% were potent at 12 months.

Conclusions

The safety and feasibility of RALP has already been established. Our initial experience with this procedure shows promising short-term outcomes.

Introduction

Tens of thousands of patients with localised prostate cancer have now undergone robotic-assisted laparoscopic radical prostatectomy (RALP) using the da Vinci® surgical system (Intuitive Surgical, Sunnyvale, CA). The feasibility and safety of this procedure have been well established since its introduction in 2000, and reports from high-volume centres suggest excellent short and medium-term functional and oncological outcomes for patients undergoing this procedure [1], [2].

We installed the first da Vinci® surgical system in Australia in 2003, and to date have performed over 800 RALPs. Four hundred of our patients have completed a minimum of one year follow-up. Our technique has evolved over five years as our experience has developed. We report and demonstrate our technique as it currently stands. The peri-operative characteristics and short-term functional and oncological outcomes for this cohort are also reported.

Section snippets

Patient selection & preparation

Following a period of training which included visits to experienced centres and da Vinci® dry and cadaveric laboratory training, two experienced open surgeons with no previous laparoscopic experience started our RALP programme in December 2003. A mentor was present for the first few cases. All patients with primary localised prostate cancer considered suitable for open radical prostatectomy were offered RALP.

Patient positioning and port placement

The patient is placed in low lithotomy position and secured to the table taking care to

Perioperative parameters

From December 2003 to August 2006, 400 consecutive patients underwent RALP at our institution. Patient characteristics and peri-operative parameters are summarized in Table 1. The mean total operative time dropped below 200 min after 50 cases and dropped to a series mean of 186 min soon after (Fig. 11). Thirty-eight patients underwent pelvic lymph node dissection.

In total, 63 patients had complications (15.75%). Of these, 42 (10.5% of series) had Clavien grade I/II complications not requiring any

Discussion

The penetration of RALP into the radical prostatectomy market in the past five years has been remarkable. Though there is no level I evidence to support its use over conventional laparoscopic radical prostatectomy (LRP) or open radical prostatectomy, reports from centres of excellence suggest RALP is a low morbidity procedure producing PSM rates of 9.3–20.9% and potency and continence rates of 70–80% and 90.2–95% respectively [1], [2], [5], [6]. Whilst debate continues about the evidence-base

Conclusions

The safety and feasibility of RALP has already been established. This paper adds to the evidence of good short-term oncological outcomes for patients undergoing RALP for localised prostate cancer. The technique of RALP continues to evolve which may lead to further improvements in oncological and functional outcomes.

Cited by (174)

  • Rectal Perforation During Pelvic Surgery

    2022, European Urology Open Science
    Citation Excerpt :

    Historical series reported an incidence of RIs during RP that ranges from 0.5% to 9%; in this setting, RI occurrence is seemingly higher during the transperineal access [4,5]. When considering open retropubic, laparoscopic, and robotic RP, the incidence of rectal perforation across a single series is summarized in Table 1 [6–20]. It has been argued that the incidence of RIs is unreported in the most recent literature likely due to a lower occurrence [3].

  • Intraoperative Adverse Incident Classification (EAUiaiC) by the European Association of Urology ad hoc Complications Guidelines Panel[Formula presented]

    2020, European Urology
    Citation Excerpt :

    The success of this system is linked to its logical design and reproducibility. The Clavien-Dindo system (CDS) has previously been applied in urological surgery [6–12]. Various authors have reported limitations when using the CDS to grade intraoperative AIs [7,11–13] as it was originally designed to report postoperative complications.

View all citing articles on Scopus

Please visit www.europeanurology.com and www.urosource.com to view the accompanying video.

View full text